Literature DB >> 16148249

Managing gastroesophageal reflux disease in primary care: the patient perspective.

Harley Liker1, Pali Hungin, Ingela Wiklund.   

Abstract

Gastroesophageal reflux disease (GERD) is a chronic disease that affects up to 20% of the population of Western countries and accounts for around 5% of a primary-care physician's workload. A better understanding of how GERD affects many aspects of patients' lives may aid the management of patients in primary care. We conducted a systematic review of the effect of GERD on health-related quality of life (HRQL) in the primary-care setting and in the community. Validated questionnaires have shown that GERD patients consulting in primary care experience substantial reductions in both physical and psychosocial aspects of HRQL, as well as work productivity. Impairments in HRQL are seen whether or not reflux esophagitis or Barrett's esophagus is present on endoscopy, and are comparable with or worse than those seen in patients with other chronic diseases such as heart disease, diabetes, and cancer. Surveys in primary care and in the community highlight disrupted sleep, reduced concentration at work, and interference with physical activities such as exercise, housework, and gardening. Psychosocial aspects of patient well-being are also impaired, including enjoyment of social gatherings, intimacy, sex, and many individuals with GERD remain worried about the underlying cause of their symptoms. In conclusion, many aspects of HRQL are impaired in GERD patients. The primary-care physician is uniquely placed to assess and address the impact of GERD on patients' lives.

Entities:  

Mesh:

Year:  2005        PMID: 16148249     DOI: 10.3122/jabfm.18.5.393

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  18 in total

1.  A debate on the roles of antireflux surgery and long term acid suppression in the management of gastro-oesophageal reflux disease.

Authors:  Stephen E Attwood; Jean Paul Galmiche
Journal:  Frontline Gastroenterol       Date:  2011-04-01

2.  The Prevalence of Gastroesophageal Reflux in Patients With Excessive Central Airway Collapse.

Authors:  Adnan Majid; Fayez Kheir; Daniel Alape; Michael Kent; Anthony Lembo; Vikram V Rangan; Megan Carreiro; Sidhu P Gangadharan
Journal:  Chest       Date:  2018-10-09       Impact factor: 9.410

3.  Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement?

Authors:  William D Chey; Reema R Mody; Esin Izat
Journal:  Dig Dis Sci       Date:  2010-04-17       Impact factor: 3.199

Review 4.  Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  Hashem B El-Serag; Stephen Sweet; Christopher C Winchester; John Dent
Journal:  Gut       Date:  2013-07-13       Impact factor: 23.059

Review 5.  Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders.

Authors:  Y Claire Dorsey; Erin J Song; David A Leiman
Journal:  Curr Gastroenterol Rep       Date:  2021-12-01

Review 6.  Health-related quality of life in patients with Barrett's esophagus: a systematic review.

Authors:  Seth D Crockett; Quinn K Lippmann; Evan S Dellon; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-10       Impact factor: 11.382

7.  Zero-Inflated Models for Identifying Relationships Between Body Mass Index and Gastroesophageal Reflux Symptoms: A Nationwide Population-Based Study in China.

Authors:  Qin Xu; Wei Zhang; Tianyi Zhang; Ruijie Zhang; Yanfang Zhao; Yuan Zhang; Yibin Guo; Rui Wang; Xiuqiang Ma; Jia He
Journal:  Dig Dis Sci       Date:  2016-03-18       Impact factor: 3.199

8.  Psychometric validation of the Japanese translation of the Quality of Life in Reflux and Dyspepsia questionnaire in patients with heartburn.

Authors:  Michio Hongo; Yoshikazu Kinoshita; Kojiro Shimozuma; Yuji Kumagai; Mitsutaka Sawada; Masahiro Nii
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

9.  Endoscopic augmentation of the esophagogastric junction with polymethylmethacrylate: durability, safety, and efficacy after 6 months in mini-pigs.

Authors:  Fernando Fornari; Carmen P F Freitag; Marcos E S Duarte; Cleber R P Kruel; Paulo R O Thomé; Paulo R S Sanches; Luise Meurer; Carlos T Z Cerski; Cesar Liberato Petzhold; Sidia M Callegari-Jacques; Sérgio G S Barros
Journal:  Surg Endosc       Date:  2009-02-28       Impact factor: 4.584

10.  Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy.

Authors:  Reema Mody; Debra Eisenberg; Likun Hou; Siddhesh Kamat; Joseph Singer; Lauren B Gerson
Journal:  Clinicoecon Outcomes Res       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.